Resmed Inc hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü üç ayda bir ödenmektedir ve son temettü hariç tarihi Nov 12, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.8971%
$0.23
Nov 12, 2025
Ödeme Sıklığı
Ödeme Oranı
Üç ayda bir
22.31%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Nov 12, 2025
$0.0919
Nov 13, 2025
Dec 18, 2025
Aug 13, 2025
$0.0924
Aug 14, 2025
Sep 18, 2025
May 7, 2025
$0.083
May 8, 2025
Jun 12, 2025
Feb 12, 2025
$0.083
Feb 13, 2025
Mar 20, 2025
Nov 6, 2024
$0.079
Nov 7, 2024
Dec 12, 2024
Aug 14, 2024
$0.0802
Aug 15, 2024
Sep 19, 2024
Dividend Grafikleri
RSMDF Kâr Payları
RSMDF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Resmed Inc'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
Resmed Inc'in temettü ödeme oranı nedir?
RSMDF'ün temettü dağıtım tarihi nedir?
Resmed Inc ne sıklıkla temettü öder?
Önemli İstatistikler
Önceki Kapanış
$25
Açılış fiyatı
$29.82
Günün Aralığı
$25 - $29.82
52 haftalık aralık
$16.57 - $30
İşlem hacmi
39
Ort.Hacim
13.1K
EPS (TTM)
9.77
Dividend yield
0.90%
Piyasa Değeri
$3.6B
RSMDF nedir?
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.